A new review of the science around the components of marijuana says the “complex interaction between phytocannabinoids and biological systems offers hope for novel treatment approaches,”...
A new study on effects of frequent marijuana use challenges a number of cannabis stereotypes, with researchers finding no association with paranoia or decreased motivation among...
A new federal funding opportunity from the National Institutes of Health (NIH) will use $8.4 million to support clinical trials on the safety and efficacy of...
Authors of a new research letter published by the Journal of the American Medical Association (JAMA) on Wednesday said there’s no evidence that states’ adoption of...
States that legalize marijuana see a “moderate relative decrease” in immigrant deportation rates compared to states where the drug remains illegal, according to a new study,...
A new study aiming to explore the efficacy of CBD as a treatment for crack use disorder found that people who took the cannabinoid had better...
A new report published by the the American Medical Association (AMA) finds that neither adult-use marijuana legalization nor the opening of retail stores in U.S. states...
A new federal study shows that enrollment in state-legal medical marijuana programs increased significantly across the U.S. in recent years. The researchers—from the Centers for Disease...
Single-dose psilocybin use is “not associated with risk of paranoia,” while other adverse effects such as headaches are generally “tolerable and resolved within 48 hours”—according to...
A recently published analysis of smokable hemp products by researchers at the National Institute of Standards and Technology (NIST) found that the vast majority of samples–about...
